Skip to main content
Premium Trial:

Request an Annual Quote

Douglas Scientific, LGC Ink Distribution Pact

NEW YORK (GenomeWeb) – LGC will distribute Douglas Scientific's Array Tape laboratory automation platform in Europe, the Middle East, and Africa, according to an agreement announced today.

Douglas Scientific is headquartered in Alexandria, Minn. Its Array Tape platform consists of a liquid handling and assay processing system, a PCR waterbath, a detection instrument, and software. The platform is "highly compatible" with Hoddesdon, UK-based LGC's KASP genotyping assays and reagents, the companies said in a statement.

"This relationship is more than extending the reach of our individual product offerings," said Darren Cook, executive vice president of business development and strategy at Douglas Scientific. "It's about the alignment of two compelling missions."

This is the second such distribution pact for Douglas Scientific this year. As PCR Insider reported in January, the company inked a similar agreement with EnviroLogix to distribute EnviroLogix's DNAble technology with its Array Tape platform.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.